Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Watertown, MA
SEC filing record 1 source field available
Fiscal year end
30 September
ENANTA PHARMACEUTICALS INC has filed 827 SEC EDGAR filings since 21 Jun 2002

SEC filing history

Showing 576-600 of 826 matching filings.

Per page
25
Current page
24
4

PRIMARY DOCUMENT

Filing date
29 Sep 2016
Reporting date
28 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

FORM 8-K

Filing date
08 Aug 2016
Reporting date
08 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Jul 2016
Reporting date
20 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Jul 2016
Reporting date
20 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Jul 2016
Reporting date
20 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Jun 2016
Reporting date
10 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 May 2016
Reporting date
11 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 May 2016
Reporting date
10 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
09 Mar 2016
Reporting date
09 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Feb 2016
Reporting date
26 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

ENANTA PHARMACEUTICALS, INC.

Filing date
19 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-35839

CT ORDER filing

Filing date
17 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Feb 2016
Reporting date
12 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K

Filing date
16 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-209542

S-8

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

SC 13G/A filing

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

CONSONANCE CAPITAL MANAGEMENT LP

Filing date
11 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .